Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug

Submitted by admin on November 23, 2020 - 10:11am

Source:

Endpoints

News Tags:

Eiger BioPharmaceuticals

Merck

FDA

progeria

Headline:

Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug

snippet:

Eiger BioPharmaceuticals $EIGR has received an FDA OK for a drug Merck licensed to them at no cost — and now reportedly plans to charge a level consistent with other ultra-rare disease medicines.

Search form

You are here

Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug

Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug